134 related articles for article (PubMed ID: 30816097)
1. [Protective action of a modified fragment of galanine in rats with doxorubicin-induced heart failure].
Studneva IM; Palkeeva ME; Veselova OM; Molokoedov AS; Lubimov RO; Ovchinnikov MV; Sidorova MV; Pisarenko OI
Biomed Khim; 2019 Jan; 65(1):51-56. PubMed ID: 30816097
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
[TBL] [Abstract][Full Text] [Related]
3. The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin.
Studneva IM; Veselova OM; Bahtin AA; Konovalova GG; Lankin VZ; Pisarenko OI
Acta Naturae; 2020; 12(1):89-98. PubMed ID: 32477603
[TBL] [Abstract][Full Text] [Related]
4. [Cardiometabolic efficacy and toxicological evaluation of a pharmacological galanin receptor agonist].
Serebryakova LI; Studneva IM; Ovchinnikov MV; Veselova OM; Molokoedov AS; Arzamastsev EV; Afanasyeva EY; Terekhova OA; Sidorova MV; Pisarenko OI
Biomed Khim; 2019 Apr; 65(3):231-238. PubMed ID: 31258147
[TBL] [Abstract][Full Text] [Related]
5. Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes.
Studneva IM; Veselova OM; Dobrokhotov IV; Serebryakova LI; Palkeeva ME; Molokoedov AS; Azmuko AA; Ovchinnikov MV; Sidorova MV; Pisarenko OI
Biochemistry (Mosc); 2022 Apr; 87(4):346-355. PubMed ID: 35527373
[TBL] [Abstract][Full Text] [Related]
6. Galanin/GalR1-3 system: A promising therapeutic target for myocardial ischemia/reperfusion injury.
Palkeeva M; Studneva I; Molokoedov A; Serebryakova L; Veselova O; Ovchinnikov M; Sidorova M; Pisarenko O
Biomed Pharmacother; 2019 Jan; 109():1556-1562. PubMed ID: 30551408
[TBL] [Abstract][Full Text] [Related]
7. Galanin receptors activation modulates myocardial metabolic and antioxidant responses to ischaemia/reperfusion stress.
Studneva I; Serebryakova L; Veselova O; Pal'keeva M; Molokoedov A; Ovchinnikov M; Konovalova G; Lankin V; Sidorova M; Pisarenko O
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1174-1182. PubMed ID: 31429479
[TBL] [Abstract][Full Text] [Related]
8. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.
Ammar el-SM; Said SA; El-Damarawy SL; Suddek GM
Pharm Biol; 2013 Mar; 51(3):339-44. PubMed ID: 23134235
[TBL] [Abstract][Full Text] [Related]
10. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
11. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin.
Hao G; Yu Y; Gu B; Xing Y; Xue M
Xenobiotica; 2015; 45(11):1024-9. PubMed ID: 25970816
[TBL] [Abstract][Full Text] [Related]
13. [Metilin Improves Сardiac Function in Rabbits With Chronic Heart Failure].
Studneva IM; Lakomkin VL; Veselova OM; Prosvirnin AV; Abramov AA; Pavlovich ER; Lubimov RO; Gramovich VV; Vyborov ON; Pisarenko OI; Kapelko VI
Kardiologiia; 2018 Jul; 58(7):66-74. PubMed ID: 30081811
[TBL] [Abstract][Full Text] [Related]
14. Gαq protein carboxyl terminus imitation polypeptide GCIP-27 improves cardiac function in chronic heart failure rats.
Lu XL; Tong YF; Liu Y; Xu YL; Yang H; Zhang GY; Li XH; Zhang HG
PLoS One; 2015; 10(3):e0121007. PubMed ID: 25822412
[TBL] [Abstract][Full Text] [Related]
15. Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.
Ahmad S; Panda BP; Kohli K; Fahim M; Dubey K
Pharm Biol; 2017 Dec; 55(1):1295-1303. PubMed ID: 28274156
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.
Ma S; Li X; Dong L; Zhu J; Zhang H; Jia Y
BMC Complement Altern Med; 2016 Feb; 16():61. PubMed ID: 26865364
[TBL] [Abstract][Full Text] [Related]
17. Galanin and its N-terminal fragments reduce acute myocardial infarction in rats.
Serebryakova L; Pal'keeva M; Studneva I; Molokoedov A; Veselova O; Ovchinnikov M; Gataulin R; Sidorova M; Pisarenko O
Peptides; 2019 Jan; 111():127-131. PubMed ID: 29730241
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity.
Ahmed F; Urooj A
Pharm Biol; 2012 Apr; 50(4):468-73. PubMed ID: 22136326
[TBL] [Abstract][Full Text] [Related]
19. Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats.
Afsar T; Razak S; Batoo KM; Khan MR
BMC Complement Altern Med; 2017 Dec; 17(1):554. PubMed ID: 29284479
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.
Matsui H; Morishima I; Numaguchi Y; Toki Y; Okumura K; Hayakawa T
Life Sci; 1999; 65(12):1265-74. PubMed ID: 10503942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
